Clinical trial
Real Life Evaluation of SGLT2 Use in Type 1 Diabetes
NCT04819178 is registered in ClinicalTrials.gov with Steno Diabetes Center Copenhagen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real Life Evaluation of SGLT2 Use in Type 1 Diabetes
- Lead sponsor
- Steno Diabetes Center Copenhagen
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- June 1, 2021
- Completion date
- December 1, 2021
- Enrollment
- 0 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.